Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H16N2O |
Molecular Weight | 240.3003 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(=CC(C)=C1)C(=O)NCC2=CC=NC=C2
InChI
InChIKey=JROSDBYIFZWPBP-UHFFFAOYSA-N
InChI=1S/C15H16N2O/c1-11-7-12(2)9-14(8-11)15(18)17-10-13-3-5-16-6-4-13/h3-9H,10H2,1-2H3,(H,17,18)
Molecular Formula | C15H16N2O |
Molecular Weight | 240.3003 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Picobenzide is a synthetic product which is of therapeutic interest owing to its neuroleptic, anti-inflammatory and spasmolytic action and because its properties are similar to those of the phenotiazines. The product is largely metabolized into the N-oxide form and is also partially eliminated in urine in an unaltered state.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Comparative study of the pharmacological activity of N-(4-picolyl)-3,5-dimethylbenzamide (M-14012-4) and its N-oxide metabolite (M-3312-4). New pharmacological aspects]. | 1979 Dec |
|
[Pharmacokinetic study of the picobenzide endovenously administered (author's transl)]. | 1980 Aug |
|
[Modification of the triphasic mortality curve of d-amphetamine]. | 1982 Dec |
|
Determination of N-oxide of picobenzide by differential pulse polarography. | 1983 Oct |
|
[Effect of MA-14012 (Dosetil) on lymphocyte mitogenesis. In vitro study]. | 1984 Jan-Feb |
|
Pharmacokinetics and initial distribution of a new neuroleptic agent picobenzide (M-14012-4). | 1985 May |
|
'In vitro' metabolism of N-picolyl-3,5-dimethylbenzamides. | 1986 Apr-Jun |
|
Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide. | 1989 Jan-Mar |
|
Synthesis and biological activity of picobenzide (3,5-dimethyl-N-(pyridin-4-ylmethyl)benzamide) analogues as potential antipsychotic agents. | 2005 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2861167
Single dose - 10 mg/kg
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:09:57 GMT 2023
by
admin
on
Fri Dec 15 16:09:57 GMT 2023
|
Record UNII |
C46317G8F0
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C016938
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
40146
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
100000081919
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL1581974
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
C76443
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
4674
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
DTXSID10199792
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
SUB09814MIG
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
C46317G8F0
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY | |||
|
51832-87-2
Created by
admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |